Session » Abstracts: Immunological Complications of Medical Therapy
- 3:00PM-4:30PM
-
Abstract Number: 1727
Duration of SARS-CoV-2 Viral Shedding After Infection Among Patients with Rheumatic Disease Using Tumor Necrosis Factor Inhibitors or Rituximab
- 3:00PM-4:30PM
-
Abstract Number: 1725
Exploring Risks of Polymyalgia Rheumatica (PMR), Giant Cell Arteritis (GCA) and Complications While Receiving Immune Checkpoint Inhibitors: Comparative Analysis
- 3:00PM-4:30PM
-
Abstract Number: 1728
Higher Oral Steroid Dose Is Associated with Worse Survival in Immune Checkpoint Inhibitor-Treated Rheumatoid Arthritis Patients with Metastatic Non-Small Cell Lung Cancer
- 3:00PM-4:30PM
-
Abstract Number: 1730
Osteoarthritis Is a Risk Factor for Inflammatory Arthritis in Cancer Patients Treated with Immune Checkpoint Inhibitors
- 3:00PM-4:30PM
-
Abstract Number: 1729
Prophylaxis Against Pneumocystis Jerovecii Pneumonia for Patients with Systemic Autoimmune Diseases: Analysis of the Veterans Affairs Database